| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.75B | 4.35B | 4.24B | 4.23B | 3.91B |
| Gross Profit | 979.04M | 1.66B | 1.56B | 815.38M | 786.31M |
| EBITDA | 334.60M | 428.44M | 371.78M | 358.51M | 390.72M |
| Net Income | 227.10M | 220.29M | 186.27M | 182.55M | 216.74M |
Balance Sheet | |||||
| Total Assets | 3.48B | 3.36B | 2.71B | 2.64B | 2.47B |
| Cash, Cash Equivalents and Short-Term Investments | 405.56M | 306.75M | 371.32M | 204.12M | 256.57M |
| Total Debt | 1.31B | 1.33B | 682.30M | 693.91M | 658.44M |
| Total Liabilities | 2.26B | 2.23B | 1.30B | 1.35B | 1.29B |
| Stockholders Equity | 1.08B | 994.05M | 1.29B | 1.17B | 1.08B |
Cash Flow | |||||
| Free Cash Flow | 244.25M | 283.00M | 222.62M | 6.71M | 103.85M |
| Operating Cash Flow | 400.17M | 406.88M | 370.14M | 211.28M | 261.26M |
| Investing Cash Flow | -206.03M | -962.93M | -135.83M | -231.10M | -430.01M |
| Financing Cash Flow | -112.00M | 507.95M | -81.08M | -23.09M | 121.29M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $4.33B | 19.08 | 18.34% | 2.26% | 10.78% | 10.53% | |
69 Neutral | CHF1.37B | 13.86 | 24.18% | ― | 0.90% | 30.62% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
53 Neutral | CHF1.35B | 19.45 | 7.93% | 3.18% | 4.59% | -3.22% | |
46 Neutral | CHF35.84M | -0.13 | ― | ― | ― | ― | |
44 Neutral | CHF76.90M | -1.78 | ― | ― | -1.86% | -303.03% |
Emmi Group delivered a strong 2025 performance despite currency headwinds and U.S. tariffs, posting 4.3% organic sales growth and 9.1% overall sales growth to CHF 4.75 billion, with EBITDA rising to CHF 492.3 million and a higher EBITDA margin of 10.4%. The acquisition of Mademoiselle Desserts sharpened Emmi’s leadership in premium desserts in Europe and the U.S., helped lift earnings, and, together with cost discipline, reduced the net debt ratio to 1.79 and supported a proposed dividend increase, while management confirmed its disciplined growth strategy, clarified its ROIC target and signalled continued, albeit moderating, organic growth for 2026.
Emmi remains resilient in a demanding environment by leveraging a decentralised model, efficiency programmes and a focus on strategic niches and growth markets such as ready-to-drink coffee and speciality cheeses. The strengthened balance sheet and refined targets on profitability and returns underscore the company’s confidence in sustaining its long-term growth trajectory and enhancing shareholder returns, even as lower milk prices and fading one-off effects are expected to temper top-line expansion in the coming year.
The most recent analyst rating on (CH:EMMN) stock is a Buy with a CHF878.00 price target. To see the full list of analyst forecasts on Emmi AG stock, see the CH:EMMN Stock Forecast page.
Emmi Group reported a 9.1% increase in 2025 net sales to CHF 4.75 billion, driven by strong organic growth of 4.3% and acquisition contributions of 7.9%, partially offset by negative currency effects of 3.1%. All divisions contributed to volume-driven organic growth, with particularly strong momentum in Switzerland and in growth markets Brazil, Chile and Mexico, while strategic niches like ready-to-drink coffee, premium desserts and specialty cheese delivered robust gains. The integration of the 2024 acquisition Mademoiselle Desserts Group and the establishment of the Emmi Desserts PowerHouse are on track, already generating synergies in Europe and the US and underscoring desserts as a key growth pillar. Despite headwinds from a strong Swiss franc and additional US tariffs, Emmi largely offset these pressures through its decentralized business model, efficiency programs and cost discipline, and it confirmed its earnings guidance at the lower end of its target ranges. Looking ahead operationally, the company is launching a new strategic platform, “nutrition+”, from 2026 to expand in health-focused functional dairy and better align its portfolio with the global health megatrend, complementing its existing indulgence and niche strategies and reinforcing its long-term growth profile.
The most recent analyst rating on (CH:EMMN) stock is a Buy with a CHF900.00 price target. To see the full list of analyst forecasts on Emmi AG stock, see the CH:EMMN Stock Forecast page.